Dr. alan kivitz to chair xbiotech's natrunix program in rheumatoid arthritis

(phase ii multicenter study is proceeding well with high anticipation) (phase ii multicenter study is proceeding well with high anticipation)
XBIT Ratings Summary
XBIT Quant Ranking